InnoVein LLC — SEC Form D Filing
InnoVein LLC filed an SEC Form D on June 26, 2026, reporting $375K raised in Medical Devices.
Form D filing details
- Filing
- SEC Form D
- Filing date
- June 26, 2026
- Amount reported
- $375K
- Round stage
- Series A
- Industry
- Medical Devices
What the company does
Revenue: No Revenues. Exemption: Rule 506(b). Incorporated: NEVADA
Problem
Existing medical options for venous insufficiency are limited, leaving many patients without effective treatment.
Solution
InnoVein develops a novel, implantable replacement valve designed to restore proper venous function.
Verdict
Investors funded InnoVein primarily due to the potential for a novel, implantable device to address a persistent, undertreated medical condition, not because of a clear path to market or identified buyer. This implicitly bet on the technical feasibility of the implant and its regulatory approval path. Upside was limited by the significant R&D and clinical trial hurdles typical for Class III medical devices, and the absence of a defined go-to-market strategy beyond the innovation itself.
Source: SEC EDGAR Form D filing